Amidst a backdrop of global economic shifts and evolving market dynamics, Asian markets have shown resilience, with key indices reflecting optimism driven by technological advancements and monetary policy expectations. Penny stocks, often associated with smaller or newer companies, continue to capture investor interest due to their potential for growth at accessible price points. By focusing on those with strong financials and clear growth prospects, investors can uncover opportunities within this segment that offer both stability and potential upside.
Top 10 Penny Stocks In Asia
Name | Share Price | Market Cap | Rewards & Risks |
Food Moments (SET:FM) | THB3.96 | THB3.91B | ✅ 4 ⚠️ 0 View Analysis > |
JBM (Healthcare) (SEHK:2161) | HK$3.05 | HK$2.48B | ✅ 3 ⚠️ 1 View Analysis > |
Lever Style (SEHK:1346) | HK$1.63 | HK$1.01B | ✅ 4 ⚠️ 1 View Analysis > |
TK Group (Holdings) (SEHK:2283) | HK$2.49 | HK$2.07B | ✅ 4 ⚠️ 1 View Analysis > |
CNMC Goldmine Holdings (Catalist:5TP) | SGD0.925 | SGD374.89M | ✅ 4 ⚠️ 1 View Analysis > |
T.A.C. Consumer (SET:TACC) | THB4.88 | THB2.93B | ✅ 3 ⚠️ 3 View Analysis > |
Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD3.15 | SGD12.4B | ✅ 5 ⚠️ 1 View Analysis > |
Livestock Improvement (NZSE:LIC) | NZ$0.95 | NZ$135.23M | ✅ 2 ⚠️ 5 View Analysis > |
Rojana Industrial Park (SET:ROJNA) | THB5.00 | THB10.1B | ✅ 3 ⚠️ 3 View Analysis > |
Lum Chang Holdings (SGX:L19) | SGD0.425 | SGD159.22M | ✅ 2 ⚠️ 2 View Analysis > |
Click here to see the full list of 977 stocks from our Asian Penny Stocks screener.
Let's uncover some gems from our specialized screener.
Bosideng International Holdings (SEHK:3998)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Bosideng International Holdings Limited operates in the apparel business in the People’s Republic of China with a market cap of HK$54.71 billion.
Operations: The company's revenue is primarily derived from Down Apparels at CN¥21.71 billion, followed by Original Equipment Manufacturing (OEM) Management at CN¥3.42 billion, Ladieswear Apparels at CN¥651.15 million, and Diversified Apparels at CN¥231.76 million.
Market Cap: HK$54.71B
Bosideng International Holdings demonstrates a strong financial position within the apparel sector, with earnings reaching CN¥25.9 billion and net income of CN¥3.51 billion for the fiscal year ending March 31, 2025. The company's debt is well managed, covered by operating cash flow at a substantial level, and its short-term assets exceed both short-term and long-term liabilities. Despite insider selling in recent months, Bosideng maintains high-quality earnings with stable weekly volatility and has not experienced significant shareholder dilution over the past year. However, its dividend yield of 5.89% lacks coverage by free cash flows, indicating potential sustainability concerns.
- Click here and access our complete financial health analysis report to understand the dynamics of Bosideng International Holdings.
- Understand Bosideng International Holdings' earnings outlook by examining our growth report.
Fangzhou (SEHK:6086)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Fangzhou Inc. offers online chronic disease management services in China and has a market cap of approximately HK$6.23 billion.
Operations: The company's revenue is derived from several segments, including CN¥507 million from wholesale, CN¥683 million from comprehensive medical services, CN¥1.59 billion from online retail pharmacy services, and CN¥93.41 million from customized content and marketing solutions.
Market Cap: HK$6.23B
Fangzhou Inc. is actively leveraging AI technology to enhance chronic disease management services in China, as evidenced by the recent launch of its proprietary XingShi Large Language Model (XS LLM). This model integrates advanced AI capabilities to improve service efficiency and personalization. The company's strategic partnerships, such as with Innovent Biologics, aim to blend digital health services with novel therapies for metabolic diseases. Despite being unprofitable, Fangzhou has a robust cash position exceeding its debt and a cash runway of over three years due to positive free cash flow growth. Recent earnings show improved sales but continued challenges in profitability.
- Get an in-depth perspective on Fangzhou's performance by reading our balance sheet health report here.
- Explore Fangzhou's analyst forecasts in our growth report.
Archosaur Games (SEHK:9990)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Archosaur Games Inc. is an investment holding company that develops mobile games in Mainland China and internationally, with a market capitalization of approximately HK$1.81 billion.
Operations: The company's revenue segment includes Computer Graphics, generating CN¥1.34 billion.
Market Cap: HK$1.81B
Archosaur Games Inc. has shown promising revenue growth, reporting CN¥634.37 million for the first half of 2025, up from CN¥439.43 million a year ago, while significantly narrowing its net loss to CN¥11.73 million from CN¥134.04 million previously. Despite being unprofitable, the company benefits from a debt-free balance sheet and an experienced management team with an average tenure of over five years. It maintains a strong cash position with short-term assets covering both short and long-term liabilities comfortably and possesses a cash runway exceeding three years based on current free cash flow trends, providing financial stability amidst ongoing challenges in achieving profitability.
- Jump into the full analysis health report here for a deeper understanding of Archosaur Games.
- Examine Archosaur Games' past performance report to understand how it has performed in prior years.
Taking Advantage
- Explore the 977 names from our Asian Penny Stocks screener here.
- Looking For Alternative Opportunities? These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Bosideng International Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com